Skip to main content

4 Result(s)

within M. Hunault Remove this filter Medicine & Public Health Remove this filter Hematology Remove this filter Intensive / Critical Care Medicine Remove this filter Oncology Remove this filter

and

  1. No Access

    Article

    Blastic variant of mantle cell lymphoma: a rare but highly aggressive subtype

    The blastic variant (BV) form of mantle cell lymphoma (MCL) is considered to be a very aggressive subtype of non-Hodgkin's lymphoma (NHL). In order to determine its clinico-biological features and response to ...

    M Bernard, R Gressin, F Lefrère, B Drénou, B Branger, S Caulet-Maugendre… in Leukemia (2001)

  2. No Access

    Article

    Influence of NPM1 and FLT3-ITD status on outcome in relapsed/refractory AML patients receiving salvage therapy including gemtuzumab ozogamicin

    P Chevallier, T Prebet, A Pigneux, M Hunault, J Delaunay, F Perry, L Lode… in Leukemia (2010)

  3. No Access

    Article

    A new Leukemia Prognostic Scoring System for refractory/relapsed adult acute myelogeneous leukaemia patients: a GOELAMS study

    A simplified prognostic score is presented based on the multivariate analysis of 138 refractory/relapsed acute myeloid leukaemia (AML) patients (median age 55 years, range: 19–70) receiving a combination of in...

    P Chevallier, M Labopin, P Turlure, T Prebet, A Pigneux, M Hunault… in Leukemia (2011)

  4. No Access

    Article

    Long-term results of a randomized phase 3 trial comparing idarubicin and daunorubicin in younger patients with acute myeloid leukaemia

    C Récher, M C Béné, B Lioure, A Pigneux, N Vey, J Delaunay, I Luquet, M Hunault… in Leukemia (2014)